AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
(From Chemical Business NewsBase - The Independent)
Jan Leschly, the former chief executive of SmithKline Beecham, is making his return to the City with the flotation of an Israeli biotech company. Mr Leschly is the chairman of D-Pharm, which is testing experimental drugs for epilepsy, strokes and Alzheimer's disease. The company is raising #15 Mm in a ...